SD

Swapnil Deepak Meher

Active Director Director DIN 10415325
DIN 10415325 First appointment Jan 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Swapnil Deepak Meher

Data last updated:

Swapnil Deepak Meher is a Director at Sakura Biotech Private Limited (since 2024). Sakura Biotech Private Limited reported revenue of ₹3.6 Lakh (FY 2025).

DIN 10415325
Primary Designation Director
First Appointment 31 Jan 2024
Oldest Company Age 3 yrs
Largest company Sakura Biotech Private Limited · ₹3.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sakura Biotech Private Limited U46309MH2023PTC412395
Director31 Jan 20242023₹3.6 Lakh (FY 2025)Active

Board colleagues of Swapnil Deepak Meher

NameDINCompanyDesignation
Pratik Deepak Meher08273769Sakura Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sakura Biotech Private Limited
Premium access

Shareholding and investment profile for Swapnil Deepak Meher

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swapnil Deepak Meher

Swapnil Deepak Meher currently holds 1 directorship: Sakura Biotech Private Limited (Director, since 31 Jan 2024, revenue ₹3.6 Lakh (FY 2025)).

Swapnil Deepak Meher was first appointed on 31 Jan 2024 as Director at Sakura Biotech Private Limited.

The current boards of Swapnil Deepak Meher's companies include Pratik Deepak Meher (Sakura Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available